Cell-Type-Specific Causal Inference Unveils Novel Targets for Parkinson's Disease

Area of Science:

• Neurogenetics
• Cell Biology
• Pharmacogenomics

Background:

• Parkinson's disease (PD) pathogenesis is complex, involving diverse neurodegenerative processes.
• The specific impact of genetic risk factors across different brain cell types is not well understood.

Purpose of the Study:

• To pinpoint cell-type-specific causal genes for Parkinson's disease.
• To connect genetic risk in PD to underlying molecular mechanisms.
• To explore potential therapeutic strategies based on genetic findings.

Main Methods:

• Utilized cell-stratified Mendelian randomization, integrating single-cell expression quantitative trait loci (eQTL) data from eight brain cell types.
• Analyzed large Parkinson's disease genome-wide association studies (GWAS) datasets.
• Performed validation, neuropathological correlation, and postmortem expression analyses.

Main Results:

• Identified 13 significant causal associations for four genes (ARL17A, ARL17B, KANSL1, LRRC37A) across seven cell types.
• ARL17A was associated with increased PD risk, while ARL17B, KANSL1, and LRRC37A showed protective effects.
• Observed cell-type-specific gene expression dysregulation correlating with disease severity. Identified raloxifene and dorzolamide as potential therapeutic modulators.

Conclusions:

• Established cell-type-specific genetic mechanisms contributing to Parkinson's disease.
• Linked PD genetic risk variants to specific molecular alterations.
• Nominated novel therapeutic targets for Parkinson's disease intervention.